BioLife Solutions, Inc. Revenue 2010–2025
BioLife Solutions, Inc. reported $96.21M of revenue for fiscal 2025. That was 17.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +100.1%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $96.21M | +17.0% |
| FY 2024 | $82.25M | -42.6% |
| FY 2023 | $143.27M | -11.4% |
| FY 2022 | $161.76M | +35.8% |
| FY 2021 | $119.16M | +147.8% |
| FY 2020 | $48.09M | +75.7% |
| FY 2019 | $27.37M | +38.6% |
| FY 2018 | $19.74M | +79.1% |
| FY 2017 | $11.02M | — |
| FY 2016 | $0 | — |
| FY 2015 | $0 | -100.0% |
| FY 2014 | $6.19M | -30.8% |
| FY 2013 | $8.95M | +58.0% |
| FY 2012 | $5.66M | +105.3% |
| FY 2011 | $2.76M | +32.5% |
| FY 2010 | $2.08M | — |
Source: BioLife Solutions, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BLFS 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
BioLife Solutions, Inc. reported $96.21M of revenue for fiscal 2025. That was 17.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +100.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for BioLife Solutions, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBioLife Solutions, Inc. — frequently asked questions
What is BioLife Solutions, Inc.'s revenue?
BioLife Solutions, Inc. (BLFS) reported revenue of $96.21M for fiscal year 2025, per its SEC filings.
How has BioLife Solutions, Inc.'s revenue changed over time?
Between fiscal 2010 and 2025, BLFS's revenue grew at roughly 29.1% per year (compound annual rate), from $2.08M to $96.21M.
Where does this data come from?
Figures are computed from BioLife Solutions, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.